|
![]() |
|
|
Famciclovir: profile and news
One-day, High-dose Famciclovir (Famvir) Therapy Cuts Healing Time ... 06 Mar 2006 Single-Dose Famvir(R) Treatment Found To Accelerate Healing Time ... Mar 3, 2006 Novartis: Strengthening Its Infectious Disease Portfolio Feb 9, 2006 Single-Day Famvir (Famciclovir) Treatment Found To Shorten the ... Jan 12, 2006 Novartis: strengthening its infectious disease portfolio Feb 7, 2006 Empiricus: our clinical journal commentator Jan 17, 2006 New Study Shows One Single Dose of Famvir Significantly Reduces ... Nov 9, 2005 Avaian flu threat to stimulate antiviral market growth Nov 11, 2005 e-coldsores.com Releases a Guide to Cold Sore Treatments Sep 29, 2005 Photo Quiz: Inflammatory Lesions on Every Finger Jul 31, 2005 Source: Ringling Bros. and Barnum & Bailey Jul 25, 2005 Common skin conditions and treatments Jun 16, 2005 Common skin conditions and treatments Jun 16, 2005 Merck's Shingles Vaccine Reduced Incidence, Severity and Duration ... Jun 4, 2005 Treatment for post-op swollen arm usually for life Apr 28, 2005 Treatment for post-op swollen arm usually for life 28 Apr 2005 Other information Indication For the treatment of acute herpes zoster (shingles); For the treatment or suppression of recurrent genital herpes in immunocompetent patients and treatment of recurrent mucocutaneous herpes simplex infections in HIV infected patients. Pharmacology Famciclovir is a prodrug that undergoes rapid biotransformation to the active antiviral compound penciclovir. Penciclovir is an anti-viral drug which has inhibitory activity against herpes simplex virus types 1 (HSV-1) and 2 (HSV-2) and varicella zoster virus (VZV). Therefore, herpes viral DNA synthesis and replication are selectively inhibited. Mechanism Of Action Famciclovir undergoes rapid biotransformation to the active antiviral compound penciclovir, which has inhibitory activity against herpes simplex virus types 1 (HSV-1) and 2 (HSV-2) and varicella zoster virus (VZV). In cells infected with HSV-1, HSV-2 or VZV, viral thymidine kinase phosphorylates penciclovir to a monophosphate form that, in turn, is converted to penciclovir triphosphate by cellular kinases. In vitro studies demonstrate that penciclovir triphosphate inhibits HSV-2 DNA polymerase competitively with deoxyguanosine triphosphate. Consequently, herpes viral DNA synthesis and, therefore, replication are selectively inhibited. Drug Category Prodrugs; Antivirals; Nucleosides and Nucleotides (08:18.32); ATC:J05AB09; ATC:S01AD07 Brand Names/Synonyms CHEMBANK1696; FCV; Famciclovir; Famciclovir 98.5; Famciclovir [Usan:Ban:Inn]; Famciclovirum [Inn-Latin]; Famvir Dosage Forms Tablet Absorption 77% Interactions Interactions for Famciclovir: Concurrent use with probenecid or other drugs significantly eliminated by active renal tubular secretion may result in increased plasma concentrations of penciclovir. The conversion of 6-deoxy penciclovir to penciclovir is catalyzed by aldehyde oxidase. Interactions with other drugs metabolized by this enzyme could potentially occur. Chemical IUPAC Name [2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)-butyl] acetate Chemical Formula C14H19N5O4 Half Life 10 hours Drug Type Approved Drug # Accession No APRD00600 CAS Registry Number 104227-87-4 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |